A new report has found that consuming a Mediterranean diet rich in fibre, mono-unsaturated fatty acids and polyphenols is linked towards improving immunotherapy response rates and progression-free survival in advanced melanoma patients. 

The study, presented at UEG Week 2022, has found that diet plays an important role in the success of immunotherapy and trials are being expanded to investigate outcomes for different tumour types, including digestive cancers.

"Our study underlines the importance of dietary assessment in cancer patients starting ICI treatment and supports a role for dietary strategies to improve patient outcomes and survival," said researcher Laura Bolte from the University Medical Center Groningen, Netherlands.